載入...
Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
The “six-and-twelve” prognostic score was proposed recently to predict survival rate in patients with unresectable hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE). However, it has not been validated externally. We validated this score and previous prognostic scores...
Na minha lista:
| 發表在: | Clin Transl Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7899857/ https://ncbi.nlm.nih.gov/pubmed/33605612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000310 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|